Desmoplasia in pancreatic ductal adenocarcinoma

Insight into pathological function and therapeutic potential

Andrew Cannon, Christopher Thompson, Bradley R. Hall, Maneesh Jain, Sushil Kumar, Surinder Kumar Batra

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Extensive desmoplasia is a prominent feature of the pancreatic ductal adenocarcinoma (PDAC) microenvironment. Initially, studies demonstrated that desmoplasia promotes proliferation, invasion and chemoresistance in PDAC cells. While these findings suggested the therapeutic potential of targeting desmoplasia in PDAC, more recent studies utilizing genetically-engineered mouse models of PDAC, which lack key components of desmoplasia, demonstrated accelerated progression of PDAC. This contrast calls into question the paradigm that desmoplasia unilaterally promotes PDAC progression and the premise of desmoplasia-targeted therapy. This review briefly examines the major reports of the tumor-promoting and-restraining roles of desmoplasia in PDAC with commentary on the gaps in our current understanding of desmoplasia in PDAC. Additionally, we discuss the studies demonstrating the heterogeneous and multifaceted nature of desmoplasia in PDAC and advocate for future areas of research to thoroughly address the various facets of desmoplasia in PDAC, reconcile seemingly contradictory reports of the role of desmoplasia in PDAC progression, and discover aspects of desmoplasia that are therapeutically actionable.

Original languageEnglish (US)
Pages (from-to)78-86
Number of pages9
JournalGenes and Cancer
Volume9
Issue number3-4
DOIs
StatePublished - Mar 1 2018

Fingerprint

Adenocarcinoma
Therapeutics
Research

Keywords

  • Cancer-associated fibroblast
  • Desmoplasia
  • Extracellular matrix
  • Pancreatic ductal adenocarcinoma
  • SHH

ASJC Scopus subject areas

  • Genetics
  • Cancer Research

Cite this

Desmoplasia in pancreatic ductal adenocarcinoma : Insight into pathological function and therapeutic potential. / Cannon, Andrew; Thompson, Christopher; Hall, Bradley R.; Jain, Maneesh; Kumar, Sushil; Batra, Surinder Kumar.

In: Genes and Cancer, Vol. 9, No. 3-4, 01.03.2018, p. 78-86.

Research output: Contribution to journalArticle

@article{0efcda798651457eade8bf416b27c82c,
title = "Desmoplasia in pancreatic ductal adenocarcinoma: Insight into pathological function and therapeutic potential",
abstract = "Extensive desmoplasia is a prominent feature of the pancreatic ductal adenocarcinoma (PDAC) microenvironment. Initially, studies demonstrated that desmoplasia promotes proliferation, invasion and chemoresistance in PDAC cells. While these findings suggested the therapeutic potential of targeting desmoplasia in PDAC, more recent studies utilizing genetically-engineered mouse models of PDAC, which lack key components of desmoplasia, demonstrated accelerated progression of PDAC. This contrast calls into question the paradigm that desmoplasia unilaterally promotes PDAC progression and the premise of desmoplasia-targeted therapy. This review briefly examines the major reports of the tumor-promoting and-restraining roles of desmoplasia in PDAC with commentary on the gaps in our current understanding of desmoplasia in PDAC. Additionally, we discuss the studies demonstrating the heterogeneous and multifaceted nature of desmoplasia in PDAC and advocate for future areas of research to thoroughly address the various facets of desmoplasia in PDAC, reconcile seemingly contradictory reports of the role of desmoplasia in PDAC progression, and discover aspects of desmoplasia that are therapeutically actionable.",
keywords = "Cancer-associated fibroblast, Desmoplasia, Extracellular matrix, Pancreatic ductal adenocarcinoma, SHH",
author = "Andrew Cannon and Christopher Thompson and Hall, {Bradley R.} and Maneesh Jain and Sushil Kumar and Batra, {Surinder Kumar}",
year = "2018",
month = "3",
day = "1",
doi = "10.18632/genesandcancer.171",
language = "English (US)",
volume = "9",
pages = "78--86",
journal = "Genes and Cancer",
issn = "1947-6019",
publisher = "SAGE Publications Inc.",
number = "3-4",

}

TY - JOUR

T1 - Desmoplasia in pancreatic ductal adenocarcinoma

T2 - Insight into pathological function and therapeutic potential

AU - Cannon, Andrew

AU - Thompson, Christopher

AU - Hall, Bradley R.

AU - Jain, Maneesh

AU - Kumar, Sushil

AU - Batra, Surinder Kumar

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Extensive desmoplasia is a prominent feature of the pancreatic ductal adenocarcinoma (PDAC) microenvironment. Initially, studies demonstrated that desmoplasia promotes proliferation, invasion and chemoresistance in PDAC cells. While these findings suggested the therapeutic potential of targeting desmoplasia in PDAC, more recent studies utilizing genetically-engineered mouse models of PDAC, which lack key components of desmoplasia, demonstrated accelerated progression of PDAC. This contrast calls into question the paradigm that desmoplasia unilaterally promotes PDAC progression and the premise of desmoplasia-targeted therapy. This review briefly examines the major reports of the tumor-promoting and-restraining roles of desmoplasia in PDAC with commentary on the gaps in our current understanding of desmoplasia in PDAC. Additionally, we discuss the studies demonstrating the heterogeneous and multifaceted nature of desmoplasia in PDAC and advocate for future areas of research to thoroughly address the various facets of desmoplasia in PDAC, reconcile seemingly contradictory reports of the role of desmoplasia in PDAC progression, and discover aspects of desmoplasia that are therapeutically actionable.

AB - Extensive desmoplasia is a prominent feature of the pancreatic ductal adenocarcinoma (PDAC) microenvironment. Initially, studies demonstrated that desmoplasia promotes proliferation, invasion and chemoresistance in PDAC cells. While these findings suggested the therapeutic potential of targeting desmoplasia in PDAC, more recent studies utilizing genetically-engineered mouse models of PDAC, which lack key components of desmoplasia, demonstrated accelerated progression of PDAC. This contrast calls into question the paradigm that desmoplasia unilaterally promotes PDAC progression and the premise of desmoplasia-targeted therapy. This review briefly examines the major reports of the tumor-promoting and-restraining roles of desmoplasia in PDAC with commentary on the gaps in our current understanding of desmoplasia in PDAC. Additionally, we discuss the studies demonstrating the heterogeneous and multifaceted nature of desmoplasia in PDAC and advocate for future areas of research to thoroughly address the various facets of desmoplasia in PDAC, reconcile seemingly contradictory reports of the role of desmoplasia in PDAC progression, and discover aspects of desmoplasia that are therapeutically actionable.

KW - Cancer-associated fibroblast

KW - Desmoplasia

KW - Extracellular matrix

KW - Pancreatic ductal adenocarcinoma

KW - SHH

UR - http://www.scopus.com/inward/record.url?scp=85052304384&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052304384&partnerID=8YFLogxK

U2 - 10.18632/genesandcancer.171

DO - 10.18632/genesandcancer.171

M3 - Article

VL - 9

SP - 78

EP - 86

JO - Genes and Cancer

JF - Genes and Cancer

SN - 1947-6019

IS - 3-4

ER -